About this trial
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.
Eligibility criteria
Qualifiers
Maternal age: 20-49 years;
Natural conception;
Single pregnancy;
Plan to have routine prenatal examinations and give birth in the research center;
Disqualifiers
Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy;
Assisted reproduction;
Multiple pregnancy;
Fetus has a known deformity or genetic defects;
Trial design
Treatments tested in this trial
- Questionnaire survey and specimen collection